These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 29693170)

  • 21. CBX8 and CD96 Are Important Prognostic Biomarkers of Colorectal Cancer.
    Song X; Tang T; Li C; Liu X; Zhou L
    Med Sci Monit; 2018 Nov; 24():7820-7827. PubMed ID: 30383736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrated regulatory mechanisms of miRNAs and targeted genes involved in colorectal cancer.
    Wang J; Yu H; Ye L; Jin L; Yu M; Lv Y
    Int J Clin Exp Pathol; 2015; 8(1):517-29. PubMed ID: 25755742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of NOX Family Genes and Their Clinical Significance in Colorectal Cancer.
    Cho SY; Kim JS; Eun HS; Kang SH; Lee ES; Kim SH; Sung JK; Lee BS; Jeong HY; Moon HS
    Dig Dis Sci; 2018 Sep; 63(9):2332-2340. PubMed ID: 29781053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of 6 Hub Proteins and Protein Risk Signature of Colorectal Cancer.
    Yue T; Liu C; Zhu J; Huang Z; Guo S; Zhang Y; Xu H; Liu Y; Wang P; Chen S
    Biomed Res Int; 2020; 2020():6135060. PubMed ID: 33376727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Large-Scale Analysis of Gene Expression Data Reveals a Novel Gene Expression Signature Associated with Colorectal Cancer Distant Recurrence.
    Alajez NM
    PLoS One; 2016; 11(12):e0167455. PubMed ID: 27935967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gab2 is a novel prognostic factor for colorectal cancer patients.
    Ding C; Luo J; Yu W; Gao S; Yang L; Chen C; Feng J
    Int J Clin Exp Pathol; 2015; 8(3):2779-86. PubMed ID: 26045784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Three Potential Tumor Markers Promote Metastasis and Recurrence of Colorectal Cancer by Regulating the Inflammatory Response: ADAM8, LYN, and S100A9.
    Liu J; Li J; Du H; Xu L; Yang Z; Yuan M; Zhang K; Li J; Xing W; Wang S; Hu T; Wang J; Wang J; Gong Q
    Comput Math Methods Med; 2022; 2022():3118046. PubMed ID: 35103068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low expression of RASSF10 is associated with poor survival in patients with colorectal cancer.
    Wang F; Li P; Feng Y; Hu YL; Liu YF; Guo YB; Jiang XL; Mao QS; Xue WJ
    Hum Pathol; 2017 Apr; 62():108-114. PubMed ID: 28041974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genome-Wide Network-Based Analysis of Colorectal Cancer Identifies Novel Prognostic Factors and an Integrative Prognostic Index.
    Hou X; He X; Wang K; Hou N; Fu J; Jia G; Zuo X; Xiong H; Pang M
    Cell Physiol Biochem; 2018; 49(5):1703-1716. PubMed ID: 30248669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of four novel hub genes as monitoring biomarkers for colorectal cancer.
    Luo D; Yang J; Liu J; Yong X; Wang Z
    Hereditas; 2022 Jan; 159(1):11. PubMed ID: 35093172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
    Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
    Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 63 signature genes prediction system is effective for glioblastoma prognosis.
    Zhang Y; Xu J; Zhu X
    Int J Mol Med; 2018 Apr; 41(4):2070-2078. PubMed ID: 29393370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of COL6A3 in colorectal cancer.
    Liu W; Li L; Ye H; Tao H; He H
    Oncol Rep; 2018 Jun; 39(6):2527-2536. PubMed ID: 29620224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for implicated genes in colorectal cancer using whole‑genome gene expression profiling.
    Sun LC; Qian HX
    Mol Med Rep; 2018 Jun; 17(6):8260-8268. PubMed ID: 29658574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of DHRS9 expression in colorectal cancer tissues and its prognostic significance.
    Hu L; Chen HY; Han T; Yang GZ; Feng D; Qi CY; Gong H; Zhai YX; Cai QP; Gao CF
    Tumour Biol; 2016 Jan; 37(1):837-45. PubMed ID: 26254099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein-protein interaction networks and modules analysis for colorectal cancer and serrated adenocarcinoma.
    Yu H; Ye L; Wang J; Jin L; Lv Y; Yu M
    J Cancer Res Ther; 2015; 11(4):846-51. PubMed ID: 26881529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrating proteomics and transcriptomics for the identification of potential targets in early colorectal cancer.
    Yang W; Shi J; Zhou Y; Liu T; Zhan F; Zhang K; Liu N
    Int J Oncol; 2019 Aug; 55(2):439-450. PubMed ID: 31268166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and characterization of ANO9 in stage II and III colorectal carcinoma.
    Li C; Cai S; Wang X; Jiang Z
    Oncotarget; 2015 Oct; 6(30):29324-34. PubMed ID: 26317553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteomics analysis of differential protein expression identifies heat shock protein 47 as a predictive marker for lymph node metastasis in patients with colorectal cancer.
    Mori K; Toiyama Y; Otake K; Fujikawa H; Saigusa S; Hiro J; Kobayashi M; Ohi M; Tanaka K; Inoue Y; Kobayashi Y; Kobayashi I; Mohri Y; Goel A; Kusunoki M
    Int J Cancer; 2017 Mar; 140(6):1425-1435. PubMed ID: 27925182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of genes related to ribosomal proteins in colorectal cancer: exploring their potential as biomarkers, prognostic indicators, and therapeutic targets.
    Salehinia N; Mohammad Al-Mosawi AK; Al-Moussawi DK; Sadeghi ES; Zamani A; Mahdevar M
    Mol Biol Rep; 2024 Apr; 51(1):576. PubMed ID: 38664314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.